← Leaderboards
Li Zeng
Tufts University Boston
$6,554,555
Attributed
$6,769,247
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,769,247 · 7
By mechanism
R01$5,098,100 · 2
R21$1,281,121 · 3
R03$241,980 · 1
F32$148,046 · 1
Top collaborators
- Nitin Joshi1 shared
Others in their field
Top investigators on “Cartilage”
- Sharmila Majumdar · University Of California San Francisco$28,026,097
- David Tobin Felson · Boston University Medical Campus$25,949,629
- Farshid Guilak · Duke University$24,637,032
- Martin K. Lotz · Scripps Research Institute$23,789,655
- Ravinder R Regatte · New York University School Of Medicine$21,004,161
- Michael C Nevitt · Boston University Medical Campus$19,578,361
Research focus
CartilageTissuesChondrocytesRegulationCytokineSignal TransductionJointsTechnologyInflammationInflammatoryDegenerative PolyarthritisSocietiesPainJoint DestructionInsightProteinsMediatingAgingGene ExpressionResponseStimulusEffective TherapyCellsResistance
Grant awards (22)
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression$524,109
R01 · FY2025 · AR · contact PI
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression$569,640
R01 · FY2024 · AR · contact PI
Impact of mast cell heterogeneity on Osteoarthritis$452,437
R21 · FY2024 · AG · contact PI
Exploring nano-bio interactions for cell-specific targeting of osteoarthritis$429,384
R21 · FY2024 · AR · contact PI
The role of Wnt7a in orchestrating immune cell-driven osteoarthritis pain$33,583
R01 · FY2024 · AR · contact PI
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression$587,306
R01 · FY2023 · AR · contact PI
Impact of Wnt7a on Mast Cell-mediated inflammation associated with Alzheimer's Disease.$412,499
R01 · FY2023 · AR · contact PI
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression$588,026
R01 · FY2022 · AR · contact PI
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression$567,271
R01 · FY2021 · AR · contact PI
Screening antibiotics using NIR fluorescence imaging for osteoarthritis treatment$181,500
R21 · FY2017 · AR · contact PI
Screening antibiotics using NIR fluorescence imaging for osteoarthritis treatment$217,800
R21 · FY2016 · AR · contact PI
Muscle Cell-Enhanced Cartilage Tissue Engineering$360,070
R01 · FY2014 · AR · contact PI
Muscle Cell-Enhanced Cartilage Tissue Engineering$349,048
R01 · FY2013 · AR · contact PI
Muscle Cell-Enhanced Cartilage Tissue Engineering$367,417
R01 · FY2012 · AR · contact PI
Muscle Cell-Enhanced Cartilage Tissue Engineering$367,417
R01 · FY2011 · AR · contact PI
Muscle Cell-Enhanced Cartilage Tissue Engineering$371,714
R01 · FY2010 · AR · contact PI
Nkx3.2 nuclear localization and cartlidge formation$80,115
R03 · FY2009 · AR · contact PI
Nkx3.2 nuclear localization and cartlidge formation$80,115
R03 · FY2008 · AR · contact PI
Nkx3.2 nuclear localization and cartlidge formation$81,750
R03 · FY2007 · AR · contact PI
Regulators of Cartilage Formation$52,492
F32 · FY2004 · AR
Regulators of Cartilage Formation$49,862
F32 · FY2003 · AR
Regulators of Cartilage Formation$45,692
F32 · FY2002 · AR